Predictive factors of macroangiopathy in type 2 diabetic patients

Imen Sebai, Ibtissem Oueslati, Nadia Khessairi, Meriem Yazidi, Emna Talbi, Fatma Chaker Mélika Chihaoui Published in the journal : October 2019 Category : Diabétologie

Cardiovascular complications are the first cause of mortality in patients with type 2 diabetes mellitus. The aim of our study was to determine the risk factors related to diabetic macroangiopathy. To meet this purpose, we conducted a cross-sectional study among 71 patients with type 2 diabetes mellitus. Patients were divided into two groups according to presence or absence of macroangiopathy. The examination included full medical histories, somatic examination and laboratory tests, in particular brain natriuretic peptide (BNP) measurements. The univariate analysis showed a significant association between macroangiopathy and male gender (p = 0.029), HbA1c > 9.5% (p = 0.008), a cumulative number of cardiovascular risk factors>5 (p <10-3), hypertension, presence of microangiopathy (p <10-3) and BNP plasmatic level > 24 pg/mL (p=0.007). In multivariate analysis, predictor factors were a cumulative cardiovascular risk factors > 5 (OR=13.9 [95%CI:1.4 -137.6], p = 0.024), presence of microangiopathy (OR=22 [95%CI: 2.2 - 215.4], p = 0.008) and HbA1c>9.5% (OR = 36.6 [95%CI:2.6 - 505]; p = 0.007). Thus, cardiovascular diseases were the consequence of the entanglement of traditional risk factors with the involvement of chronic hyperglycemia.

Read more

35 recommendations for end-of-life support at the Grand Hôpital de Charleroi

Emmanuelle Claes (1), Vanessa Baio (2), Yannick Courtin (3) Published in the journal : October 2019 Category : Soins palliatifs

Caregivers in charge of end-of-life patients are often helpless and experience difficulty when their patients do approach death. Heavy emotions manifest and several questions come up. This is a common observation.

Most naturally, this emphasizes the necessity of a project involving caregivers’ knowledge of death outside palliative care. Such a project was built over 3 years of meetings, consultations with eight teams of caregivers, questions, seminar sessions and presentations, transcripts, proofreading, in addition to numerous corrections.

The outcome is a set of 35 recommendations stemming from the «practical wisdom» of caregivers. This document bears witness to a process of care within this field, a process which designates a movement, bringing one towards the other in order to meet him on his own path [6]. This approach brought together caregivers from eight disciplines around the same questioning in order to broaden and ameliorate their own skills, while sharing them with the different stakeholders working on the quality of care within an institution.

This project is now evolving and primarily designed to encourage consultation and implementation of the recommendations, while further seeking for partnerships in this field.

Read more

Improving ovarian cancer management through centralized surgery: experience gained by the UNGO after one year of collaboration and obtaining ESGO accreditation in 2019

Mathieu Luyckx (1,6,8), Mathieu Jouret (1,2), Frédéric Grandjean (1,3), Marc Waterkeyn (1,4), Jean-Paul Van Gossum (1,5), Nathanael Dubois (1,5), Jean-François Baurain (7,8) Jean-Luc Squifflet (1,8) Published in the journal : October 2019 Category : Gynécologie et Andrologie

Ovarian cancer treatment combines optimal surgery with platine-based chemotherapy. The quality of the surgery, which is the cornerstone of the treatment, must be complete (no residual disease after the procedure). Owing to its central role, the European Society of Gynaecological Oncology (ESGO) has published objective criteria to evaluate the quality of surgery quality, providing gynecological oncology centers with the opportunity to be accredited for ovarian cancer surgery. In 2016, a centralisation network for ovarian cancer surgery was formed. Like others Belgian networks for rare cancers, this network primarily aimed to increase the experience of surgeons within the reference centers by increasing the number of cases, yet still enabling surgeons in other centres to perform oncological pelvic surgery and become referents of their respective centres. The UNGO (UCL Network of Gynaecological Oncology) centralizes all surgeries in the Cliniques Universitaires Saint-Luc (CUSL), with the remaing of the treatment and check-ups staying under the responsibility of collaborating centers. Five hospitals have been involved: CUSL Brussels, CHWaPi Tournai, Saint-Michel, Sainte-Elisabeth, and Saint-Jean in Brussels. After a 1-year collaboration, 40 patients underwent ovarian cancer surgery within the UNGO, and 91% of them underwent complete surgery with no residual disease (R0). The results of this first year of collaboration were deemed satisfying and we will thus continue on this path. We have thus demonstrated that centralization of ovarian cancer surgery is possible in Belgium. In 2019 the ESGO awarded for 5 years an accreditation to UNGO network and CUSL for cancer surgery advanced ovarian. Two additional centers since joined the UNGO: CSPO and Roccourt.

Read more

Severe hypomagnesemia induced by proton pump inhibitors: description of two cases and review of the literature

Matveï Apraxine(1,2), Pierre Levecque†(3), Patrick Druez(1), Karin Dahan(4) Jean-François Cambier(2), Jean-Philippe Lengelé(2) Published in the journal : September 2019 Category : Gastroenterology

Proton pump inhibitors, an essential treatment of gastric acid-related disorders, can cause hypomagnesemia, associated with functional hypoparathyroidism and hypocalcemia. Symptoms may be either minor like cramps or more severe like rhabdomyolysis, cardiac arrhythmias, or epilepsy. We have herein reported on two cases presenting with severe hypomagnesemia, which quickly resolved following drug withdrawal. We have additionally reviewed the underlying mechanism, which is only partially elucidated to date, though possibly linked to a reduced intestinal absorption of magnesium, which as dependent on the channel TRPM6 (transient receptor potential melastatin type 6).

Read more

Dermatology and internal medicine

Marine Beeckman (1), Deborah Debois (1), Didier Bessis (2), Marie Baeck (1) Published in the journal : September 2019 Category : Dermatology

We herein report on the «PEAUse dermatologique» meeting of the Cliniques universitaires Saint-Luc held on May 14, 2018, which was focused on the topic “dermatology and internal medicine”.

For this occasion, Professor Didier Bessis, head of the Dermatology department of the CHU Montpellier and specialist in the care of rare dermatological diseases, presented us some clinical cases and four examples of new clinical entities in dermatology.

Read more

Familial pulmonary fibrosis and telomeropathies

Thomas Planté-Bordeneuve (1,2), Xavier Poiré (3), Anne De Leener (4), Antoine Froidure (1,2) Published in the journal : September 2019 Category : Pneumology

Germline mutations in genes related to telomere biology are the first cause of familial pulmonary fibrosis. The progressive shortening of these protective structures successively leads to cell cycle arrest, cellular exhaustion, and the possible development of lung fibrosis. This process may also involve hematopoiesis, the liver, and the skin. The most common pulmonary feature is an early-onset, rapidly progressive pulmonary fibrosis, leading to terminal respiratory insufficiency.

The multisystemic features, early disease onset, and familial component are key hallmarks of the disease. Diagnosis is primarily based on measuring telomere length and identifying a germline mutation. The management of the affected patients is rather complex, because of their rapidly progressive fibrosis, while the effects of antifibrotic drugs are limited, and the patients prone to develop drug-related undesirable events.

The Cliniques universitaires Saint-Luc have set up a specific program, in close collaboration with pneumologists, hematologists, and geneticists, designed to offer optimal care to this patient population.

Read more

Damage Control Management: from the surgical concept to multidisciplinary care for selected patients

Jean-Paul Lechat Published in the journal : September 2019 Category : Anesthésie-Réanimation

Initially considered specific for the severe polytraumatized patients, the concept of damage control (DC) has been extended to the acute medicine domain with a climax attained following recent attacks. As a result, this condition now mobilizes a series of actors from the chain of care.

In the pre-hospital setting, the DC with its requirement of early bleeding control consisting of setting a tourniquet and a pelvic belt has modified the ABC trilogy into C-ABC: "Control hemorrhages first", prior to "Airway - Breathing - Circulation". In the emergency setting, during the "golden hour", the team leader must assume four different tasks: supervise the lifesaving procedures, initiate the massive transfusion protocols, limit any additional workup to the essentials, and schedule the priority of the surgical action order.

In the operating room, the carrying out of interventions aimed at controlling bleeding and microbial contamination, along with tolerating unstandardized parameters except for temperature control upon admission, must be performed in the second hour, the speed of surgery being now the priority. In the ICU, homeostasis restoration within 36 hours should enable a secondary surgical procedure for anatomical and functional purposes to be conducted. At times, maybe even often, several intermediary interventions are necessary in order to perfectly control the hemorrhage and infection prior to undertaking the final surgery.

Read more

Geriatric Day Hospital : an ambulatory interface for elderly people

Didier Schoevaerdts (1), Christophe Dumont (2), Pierre Hanotier (3), Alain Fournier (4), Dominique Piette (5), Carole Almpanis (6), Serge Biettlot (1), Françoise Detraux (1), Mélanie Sentrie (1), François-Xavier Sibille (1), Pascale Cornette (7) Published in the journal : September 2019 Category : Geriatry

The Geriatric Day Hospital is an ambulatory structure where a diagnostic and therapeutic approach is offered to old frail adults. This is a good therapeutic option, considered to be an alternative to a conventional hospital stay. This article was aimed to describe Belgian geriatric day hospitals based on existing medical literature. It also reports on the history of these geriatric day hospitals, both in Belgium and worldwide. This article has also presented and commented the results, along with comments, pertaining to a meta-analysis and national surveys published since 2007. Compared to published studies, Belgian Geriatric Day Hospitals are more oriented to diagnosis rather than rehabilitation, which is less developed. Day hospitals represent a good opportunity for a comprehensive geriatric assessment performed by an interdisciplinary team and designed to assess geriatric syndromes reflected by functional decline, frailty, falls, memory complaints, poor nutrition, etc. They are considered to constitute a good link between hospitals, general practitioners, and the healthcare network.

Read more

Glucocorticoid-induced muscle atrophy: clinical presentation, physiopathological mechanisms, and therapeutic implications

Pauline Montigny (1), Jean-Paul Thissen (2) , Bernard Lauwerys (3), Frédéric Houssiau (3) Published in the journal : September 2019 Category : Rheumatology

Glucocorticoids (GC) are used in all medical areas because of their anti-inflammatory and immunosuppressive effects. Their undesirable effects are, however, much feared, in particular cortisone-induced myopathy (CD). This condition is characterized by insidious muscle atrophy, exhibiting an important prognostic role. CD is related to the GC-induced imbalance between muscle protein synthesis and degradation, promoting their degradation yet inhibiting their synthesis. We have herein undertaken a review focused on CD’s main pathophysiological mechanisms, along with a discussion on potential targets, such as myostatin, activin receptor Type IIB, TRAF6, and REDD1. To end with, practical recommendations for the fight against CD have been developed, including resistance exercises.

Read more

Semaglutide (Ozempic®), a new weekly GLP- 1 analogue for the treatment of type 2 diabetes mellitus

Michel P. Hermans Published in the journal : July 2019 Category : Actualité thérapeutique

Semaglutide is a GLP-1 analogue recently marketed in Belgium for the treatment of hyperglycaemia in patients with type 2 diabetes, by weekly subcutaneous administration. Among GLP-1 receptor agonists, semaglutide, at a maintenance dose of 0.5 or 1.0 mg/week, is currently the most effective compound for reducing chronic hyperglycaemia and body weight, as monotherapy or in combination with other hypoglycaemic medications, including basal insulin. The SUSTAIN 6 study also suggests a clinical benefit at the cardiovascular level. The tolerance and safety of semaglutide are comparable to those of other GLP-1 receptor agonists currently available in Belgium

Read more